Strategic Portfolio Management in Drug Development Training Course

Course Title: Strategic Portfolio Management in Drug Development Training Course

Executive Summary

This intensive two-week course provides a comprehensive overview of strategic portfolio management within the context of drug development. Participants will learn to apply portfolio management principles to optimize resource allocation, prioritize projects, and maximize the value of their drug development pipeline. The course covers key topics such as portfolio strategy development, project valuation, risk management, decision-making frameworks, and portfolio governance. Through interactive workshops, case studies, and simulations, attendees will gain practical skills to effectively manage their drug development portfolio and drive strategic objectives. The course emphasizes alignment with corporate goals, maximizing return on investment, and mitigating risks inherent in the drug development process. Ultimately, participants will be equipped to make informed decisions that enhance the overall success of their organization’s drug development efforts.

Introduction

The drug development landscape is characterized by high costs, long timelines, and significant uncertainty. Effective strategic portfolio management is crucial for pharmaceutical and biotechnology companies to navigate these challenges and maximize the return on their research and development investments. This course provides a comprehensive framework for managing drug development portfolios, from early-stage research to late-stage clinical trials and commercialization. Participants will learn how to align their portfolio with corporate strategy, assess the value of individual projects, prioritize investments based on risk and reward, and make informed decisions throughout the drug development lifecycle. The course will also cover key aspects of portfolio governance, resource allocation, and performance measurement. By integrating strategic planning with portfolio management, companies can optimize their drug development efforts and enhance their competitive advantage.

Course Outcomes

• Develop a strategic framework for managing a drug development portfolio.
• Apply portfolio management principles to prioritize drug development projects.
• Assess the value of drug development projects using financial and strategic metrics.
• Implement risk management strategies to mitigate risks in the drug development process.
• Utilize decision-making frameworks to optimize portfolio resource allocation.
• Establish effective portfolio governance mechanisms to ensure alignment with corporate goals.
• Measure and track portfolio performance to drive continuous improvement.

Training Methodologies

• Interactive lectures and presentations.
• Case study analysis and group discussions.
• Hands-on workshops and simulations.
• Real-world examples and industry best practices.
• Expert panel discussions and Q&A sessions.
• Individual and group project assignments.
• Portfolio management software demonstrations.

Benefits to Participants

• Enhanced understanding of strategic portfolio management principles.
• Improved skills in project valuation and prioritization.
• Greater confidence in making informed investment decisions.
• Ability to align drug development efforts with corporate strategy.
• Expanded network of industry peers and experts.
• Increased career opportunities in portfolio management.
• Certification of completion in Strategic Portfolio Management in Drug Development.

Benefits to Sending Organization

• Optimized allocation of resources across the drug development portfolio.
• Improved project selection and prioritization processes.
• Increased return on investment in drug development.
• Reduced risk and uncertainty in the drug development process.
• Enhanced alignment between drug development and corporate strategy.
• Improved decision-making at all levels of the organization.
• Increased competitiveness in the pharmaceutical and biotechnology industry.

Target Participants

• Portfolio Managers
• Project Managers
• Research and Development Directors
• Clinical Trial Managers
• Business Development Managers
• Finance Professionals
• Strategic Planning Executives

WEEK 1: Foundations of Strategic Portfolio Management in Drug Development

Module 1: Introduction to Strategic Portfolio Management

1. Overview of strategic portfolio management principles.
2. Importance of portfolio management in drug development.
3. Key stakeholders and their roles in the portfolio management process.
4. Aligning portfolio management with corporate strategy.
5. Understanding the drug development lifecycle.
6. Challenges and opportunities in drug development portfolio management.
7. Introduction to portfolio management tools and techniques.

Module 2: Portfolio Strategy Development

1. Defining portfolio objectives and goals.
2. Analyzing the external environment (market, competition, regulatory landscape).
3. Assessing internal capabilities and resources.
4. Identifying strategic opportunities and threats.
5. Developing a portfolio strategy that aligns with corporate goals.
6. Setting portfolio priorities and resource allocation guidelines.
7. Communicating the portfolio strategy to stakeholders.

Module 3: Project Valuation and Prioritization

1. Understanding different project valuation methods (NPV, IRR, rNPV).
2. Assessing the commercial potential of drug development projects.
3. Evaluating the technical feasibility of drug development projects.
4. Incorporating risk and uncertainty into project valuation.
5. Prioritizing projects based on strategic fit, value, and risk.
6. Using scoring models and decision matrices to support project prioritization.
7. Developing a portfolio roadmap that outlines key milestones and timelines.

Module 4: Risk Management in Drug Development Portfolios

1. Identifying key risks in the drug development process (technical, regulatory, commercial).
2. Assessing the likelihood and impact of different risks.
3. Developing risk mitigation strategies (contingency plans, risk transfer).
4. Monitoring and controlling risks throughout the drug development lifecycle.
5. Incorporating risk management into project valuation and prioritization.
6. Using risk management tools and techniques (Monte Carlo simulation, sensitivity analysis).
7. Communicating risk information to stakeholders.

Module 5: Decision-Making Frameworks for Portfolio Management

1. Understanding different decision-making styles and biases.
2. Using structured decision-making frameworks (decision trees, influence diagrams).
3. Incorporating stakeholder input into the decision-making process.
4. Making decisions under uncertainty.
5. Evaluating the potential impact of different decisions.
6. Communicating decisions to stakeholders.
7. Monitoring and evaluating the outcomes of decisions.

WEEK 2: Advanced Topics in Strategic Portfolio Management

Module 6: Portfolio Governance and Resource Allocation

1. Establishing a portfolio governance structure (roles, responsibilities, decision-making authority).
2. Developing portfolio management policies and procedures.
3. Allocating resources across the portfolio based on strategic priorities.
4. Managing conflicts of interest.
5. Ensuring transparency and accountability.
6. Monitoring and enforcing compliance with portfolio management policies.
7. Reviewing and updating the portfolio governance structure on a regular basis.

Module 7: Performance Measurement and Reporting

1. Identifying key performance indicators (KPIs) for the drug development portfolio.
2. Collecting and analyzing data to track portfolio performance.
3. Developing reports that communicate portfolio performance to stakeholders.
4. Using performance data to identify areas for improvement.
5. Benchmarking portfolio performance against industry standards.
6. Setting performance targets and goals.
7. Rewarding and recognizing high-performing projects and teams.

Module 8: Advanced Project Valuation Techniques

1. Real Options Analysis in Drug Development.
2. Monte Carlo Simulation for Risk Assessment.
3. Valuation of Platform Technologies.
4. Incorporating Competitive Dynamics into Valuation.
5. Scenario Planning for Project Valuation.
6. Valuation of Combination Therapies.
7. Advanced Sensitivity Analysis Techniques.

Module 9: Portfolio Optimization Strategies

1. Dynamic Portfolio Rebalancing.
2. Strategic Resource Allocation Models.
3. Applying Game Theory to Portfolio Management.
4. Balancing Early-Stage vs. Late-Stage Projects.
5. Portfolio Diversification Strategies.
6. Managing Portfolio Dependencies and Synergies.
7. Using AI and Machine Learning for Portfolio Optimization.

Module 10: Future Trends in Drug Development Portfolio Management

1. Impact of Personalized Medicine on Portfolio Strategy.
2. Role of Digital Health and Data Analytics.
3. Emerging Technologies and Their Portfolio Implications.
4. Adapting to Changes in the Regulatory Landscape.
5. The Future of Portfolio Governance.
6. Developing a Flexible and Adaptive Portfolio Management System.
7. Building a Culture of Innovation in Drug Development.

Action Plan for Implementation

1. Conduct a comprehensive assessment of the current drug development portfolio.
2. Develop a strategic portfolio management framework that aligns with corporate goals.
3. Implement a project valuation and prioritization process based on strategic fit, value, and risk.
4. Establish a risk management program to mitigate risks in the drug development process.
5. Implement decision-making frameworks to optimize portfolio resource allocation.
6. Establish a portfolio governance structure that ensures alignment with corporate goals.
7. Measure and track portfolio performance to drive continuous improvement.